An Appraisal of Good Regulatory Review Practices in the Gulf Cooperation Council States

Abstract

The aim of this study was to evaluate how each Gulf Cooperation Council (GCC) regulatory authority is building quality into the assessment and registration process and to establish opportunities for the exchange of best practice between the GCC states. A questionnaire was completed by the 7 Gulf States (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates [UAE], and Yemen), which provided details of the quality attributes that characterize the extent of the scientific assessment in the region. The results showed that each authority has its unique practices that characterize their 7 milestones in comparison with the other GCC authorities. Bahrain uses good review practice (GRP) guidelines and has placement arrangements in competent authorities, while Kuwait has separate pricing and registration departments. Oman engages external audit programs from accredited bodies, while Saudi Arabia and UAE conduct formal training for their assessors.

Keywords

good review practice regulatory review quality measures assessment templates

Get full access to this article

View all access options for this article.

References

Brown

Franco

Rafeh

Halzel

. Quality assurance of health care in developing countries. In: Quality Assurance Methodology Refinement Series. Bethesda, MD: Quality Assurance Project. http://www.hrhresourcecenter.org/node/796. Published 1998. Accessed April 2011.

Breckenridge

Woods

. Medicines regulation and the pharmaceutical industry. BMJ. 2005;331:834–836.

Smith

. Building quality measures into the regulatory review process. International Journal of Pharmaceutical Medicine. 2001;15:115.

McAuslane

Cone

Collins

Walker

. building quality into regulatory activities: what does it mean? R&D Briefing No. 46. Surrey, UK: CMR International Institute for Regulatory Science. http://www.cmr.org/institute. Published 2006. Accessed April 2011.

Donabedian

. Evaluating the quality of medical care. Milbank Quarterly. 2005; 83:691–729.

Deng

Kaitin

. The regulation and approval of new drugs in China. Drug Information Journal. 2004;37:29–39.

Mallia-Milanes

. The Development and Application of Scorecards to Assess the Quality of Regulatory Submissions and Their Review [PhD thesis]. Cardiff, UK: Welsh School of Pharmacy, Cardiff University; 2010.

Mourshed

Hedigar

Lambert

(2007). Gulf Cooperation Council healthcare: challenges and opportunities. Arab World Competitiveness Report (Part 5). 2007;55–64.

Hashan

. Evaluation of the Review Process for Marketing Pharmaceutical Products in the Gulf States and Its Impact on Patients’ Access to Medicines [PhD thesis]. Cardiff, UK: Welsh School of Pharmacy, Cardiff University; 2005.

10.

Transparency—in the eye of the beholder? [editorial]. Australian Prescriber. 2005;28:83–84.